Delving into the Latest Updates on Foshan Rui Diao Pharmaceutical Co Ltd with Synapse

Overview

Tags

Neoplasms

Respiratory Diseases

Diagnostic radiopharmaceuticals

Synthetic peptide

Peptide Conjugate Radionuclide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	2

Top 5 Drug Type	Count

Diagnostic radiopharmaceuticals	2
Synthetic peptide	1
Peptide Conjugate Radionuclide	1

Top 5 Target	Count

αvβ3(Integrin alpha-V/beta-3)	1

Primary objective: To evaluate the effectiveness of technetium [99mTc] hydrazinonicotinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2) in the diagnosis of lymph node metastasis of lung tumors. Secondary objectives: To evaluate the effectiveness of 99mTc-3PRGD2 in the differential diagnosis of benign and malignant lung tumors; to evaluate the safety of 99mTc-3PRGD2 in humans.

Start Date05 Nov 2019

Sponsor / Collaborator

Institute of Biophysics of Chinese Academy of Sciences

[+2]

CTR20182365 / CompletedPhase 1

锝[99mTc]肼基烟酰胺聚乙二醇双环RGD 肽注射液在健康志愿者体内的药代动力学和安全性的I 期临床研究

[Translation] Phase I clinical study on the pharmacokinetics and safety of technetium [99mTc] hydrazinonicotinamide polyethylene glycol bicyclic RGD peptide injection in healthy volunteers

检测锝[99mTc]肼基烟酰胺聚乙二醇双环RGD 肽（99mTc-3PRGD2）注射液在健康志愿者体内的药代动力学，以及在人体内的生物分布及估算内照射辐射吸收剂量，为II期临床研究方案设计提供依据；观察99mTc-3PRGD2对健康志愿者的安全性。

[Translation]

To examine the pharmacokinetics of technetium [99mTc] hydrazinonicotinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2) injection in healthy volunteers, as well as its biodistribution in humans and estimate the internal radiation absorbed dose, to provide a basis for the design of a Phase II clinical study; to observe the safety of 99mTc-3PRGD2 in healthy volunteers.

Start Date07 Dec 2018

Sponsor / Collaborator

Institute of Biophysics of Chinese Academy of Sciences

[+2]

100 Clinical Results associated with Foshan Rui Diao Pharmaceutical Co Ltd

Login to view more data

0 Patents (Medical) associated with Foshan Rui Diao Pharmaceutical Co Ltd

Login to view more data

100 Deals associated with Foshan Rui Diao Pharmaceutical Co Ltd

Login to view more data

100 Translational Medicine associated with Foshan Rui Diao Pharmaceutical Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

2

NDA/BLA

Login to view more data